Saba Husain

Synthesis and Structure−Activity Relationships of Novel Arylpiperazines as Potent and Selective Agonists of the Melanocortin Subtype-4 Receptor

Timothy I. Richardson, Paul L. Ornstein, Karin Briner et al. · Journal of Medicinal Chemistry · 2004 · 61 citations · Full text

Drug Target, Novel Arylpiperazines, Pharmacotherapy +18

Open Innovation for Phenotypic Drug Discovery: The PD2 Assay Panel

Jonathan A. Lee, Shaoyou Chu, Francis S. Willard et al. · SLAS DISCOVERY · 2011 · 54 citations · Full text

A Novel and Selective β-Melanocyte-Stimulating Hormone-Derived Peptide Agonist for Melanocortin 4 Receptor Potently Decreased Food Intake and Body Weight Gain in Diet-Induced Obese Rats

Hansen M. Hsiung, JeAnne Hertel, Xing-yue Zhang et al. · Endocrinology · 2005 · 25 citations · Full text

Privileged structure-based ligands for melanocortin receptors—tetrahydroquinolines, indoles, and aminotetralines

Matthew J. Fisher, Ryan T. Backer, Saba Husain et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 24 citations · Full text

Molecular Pharmacology, Medicine, Receptor (Biochemistry) +2

Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of Assays

Jonathan A. Lee, Paul Shinn, Susan Jaken et al. · PLoS ONE · 2015 · 22 citations · Full text

Proven Track Record, Pharmacotherapy, Pubchem Database +18